Skip to main content

Latest results

Clariant delivered strong Catalysts performance and stabilization in Care Chemicals in a continued challenging market environment

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q3 2023 sales decreased by 8 % organically vs. Q3 2022 (13 % including scope) in local currency to CHF 1.031 billion; organic sales vs. Q2 2023 showed 2 % volume improvement in challenging markets
  • Catalysts achieved volume growth and positive pricing; Care Chemicals showed stabilization; Additives business faced continuing weaker demand for durable goods
  • Q3 2023 reported EBITDA margin decreased to 15.4 % vs. 16.8 % in Q3 2022; underlying improvement of 340 basis points vs. Q2 2023, driven by proactive cost measures and operational improvements
  • 9M 2023 sales decreased by 7 % in local currency to CHF 3.315 billion
  • 9M 2023 reported EBITDA margin decreased to 15.1 % vs. 16.9 % in 9M 2022
  • Full Year 2023 outlook confirmed

"Our performance is improving, despite continued uncertainties and risks related to the geopolitical and economic environment. On a Group basis Clariant has delivered an underlying sequential quarterly increase of 21% in EBITDA. Organic Group volumes increased slightly compared to the previous quarter, although weak demand for durable goods persisted, which primarily affected our Additives business. Our proactive measures to adjust our cost base are improving profitability with over CHF 120 million of savings achieved to date out of our CHF 170 million commitment. This, together with our underlying performance improvement, underpinned our strong cash generation in the third quarter. In addition, we continue to see strong Catalysts performance, both in volume and pricing. Despite a continued soft recessionary environment and currency headwinds, we expect to land in our guidance range for 2023. Our focused specialty chemicals portfolio and our highly committed people leave us well-positioned for profitable growth as end markets recover" said Conrad Keijzer, Chief Executive Officer of Clariant.

Read more


Clariant published its Third Quarter / Nine Month Figures 2023 on 30 October 2023.

Conference call and webcast

A live audio webcast and conference call took place the same day at 3 pm CET.

Feel free to follow the replay of the > WEBCAST

Alternatively, you can listen to the podcast of the conference call.

Q3 2023 Conference call podcast

Catalysts improvement on track, Care Chemicals and Additives impacted by macroeconomic challenges – Clariant achieved strong Operating Cash Flow

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q2 2023 sales decreased by 7 % in local currency, down 17 % in Swiss francs to CHF 1.084 billion
  • Q2 2023 reported EBITDA margin at 16.1 % from 16.6 % in Q2 2022
  • H1 2023 sales decreased by 3 % in local currency, down 11 % in Swiss francs to CHF 2.284 billion
  • H1 2023 reported EBITDA margin at 15.0 % from 17.0 % in H1 2022
  • H1 2023 Operating Cash Flow at CHF 78 million compared to CHF - 17 million in H1 2022
  • Full Year 2023 Outlook: Full year sales between CHF 4.55 – 4.65 billion and reported EBITDA expected between CHF 650 – 700 million (14.3 % – 15.1 % reported EBITDA margin)

"As indicated in early July, the challenging economic conditions affected the specialty chemicals sector and also impacted Clariant’s first-half year results. Our customers continued to bring their inventories down, and demand was weak in Care Chemicals and Additives, which impacted our profitability. We are pleased with our continued improvements in the Catalysts business, and we achieved further progress in reducing the negative sunliquid® impact on our results in the second quarter. Our stronger results in Catalysts partially offset the weaker trading results in the other business units. We implemented additional actions to align our cost base to a low volume environment, thereby increasing our 2025 targeted savings by CHF 10 million to a revised goal of CHF 170 million. We also continued our strong focus on cash, resulting in an improved operating cash flow by almost CHF 100 million compared to last year," said Conrad Keijzer, Chief Executive Officer of Clariant.

Read more


Clariant published its Second Quarter / First Half Year Results 2023 on 28 July 2023.

Conference call and webcast

A live audio webcast and conference call took place the same day at 3 pm CEST.

Feel free to access the podcast of the conference call.

Clariant delivers resilient sales performance in challenging environment

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q1 2023 sales increased by 1 % in local currency, down 5 % in Swiss francs to CHF 1.200 billion – positive pricing contribution of 7 %
  • Q1 2023 EBITDA down 24 % to CHF 167 million, EBITDA margin of 13.9 %, mainly attributable to 7 % lower volumes and business mix, CHF 13 million negative sunliquid® impact, and a CHF 11 milllion negative one-off fair value adjustment of the Heubach Group participation
  • Closing of North American Land Oil business divestment on 31 March 2023
  • Unchanged Outlook 2023

“Clariant delivered a resilient top-line result in the first quarter, despite the macroeconomic headwinds. Our customers have reduced their inventory, and demand in some areas has been weaker, which, coupled with the negative extraordinary factors recorded in the quarter, impacted our profitability. Overall, we have weathered the current global economic headwinds well, thanks to the actions we have taken in recent quarters to execute a strong pricing policy, implement our new organizational model, structurally improve our portfolio, and foster our sustainable product range. This is underpinned by the fact that our cash generation continued its positive momentum in the first three months of 2023. We maintain our full year expectations, however uncertainties and risks related to the economic environment remain,” said Conrad Keijzer, Chief Executive Officer of Clariant.

Read more


Clariant published its First Quarter Figures 2023 on 5 May 2023.

Conference call and webcast

A live audio webcast and conference call took place the same day at 3 pm CEST.

Feel free to access the podcast of the conference call.

Record 2022 sales growth, EBITDA and cash conversion driven by strong operating performance; dividend increase proposed

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q4 2022: Sales grew by 12 % in local currency to CHF 1.323 billion, underpinned by strong pricing in a softening demand environment, EBITDA margin was 11.6 % (14.7 % excluding CHF 40 million restructuring charges related to the implementation of the new operating model)
  • FY 2022: Sales increased by 24 % in local currency to CHF 5.198 billion, EBITDA margin was 15.6 % (16.4 % excluding CHF 40 million restructuring charges in Q4 2022 related to the implementation of the new operating model)
  • FY 2022: Net result for total Group at CHF 116 million
  • FY 2022: Net operating cash flow increased by 38 % to CHF 502 million, CHF 293 million free cash flow resulting in a 36 % free cash flow conversion
  • FY 2022: Increased distribution of CHF 0.42 per share proposed to AGM on 4 April 2023
  • Outlook 2023: Full year sales around CHF 5 billion with the aim to slightly improve the year-on-year reported Group EBITDA margin level in a challenging macro environment, which is expected to improve in H2 2023

Read more...


Clariant published its Forth Quarter / Full Year Results 2022 on 2 March 2023.

CONFERENCE CALL AND WEBCAST

A live audio webcast and conference call took place the same day at 3 pm CEST.

Feel free to access the podcast of the conference call.

Clariant generated double-digit sales and EBITDA growth in Q3 2022

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q3 2022: Sales increased by 27 % in local currency to CHF 1.312 billion, supported by both pricing and volume growth, EBITDA margin increased to 16.8 % versus 15.5 %
  • 9M 2022: Sales increased by 29 % in local currency to CHF 3.875 billion, EBITDA margin increased to 16.9 % versus 16.2 %
  • Clariant signs definitive agreement to sell North American Land Oil business
  • Full Year 2022 Outlook: Strong local currency growth for the Group to around CHF 5.1 billion, with the confirmed aim to improve the year-on-year underlying Group EBITDA margin level. Full year 2022 reported Group EBITDA margin will be impacted by restructuring charges in Q4 2022 related to the implementation of the new operating model

Read more...


Clariant published its Third Quarter / Nine Month Figures 2022 on 27 October 2022.

CONFERENCE CALL AND WEBCAST

A live audio webcast and conference call took place the same day at 3 pm CEST.

Feel free to access the podcast of the conference call.

Clariant delivered strong sales growth and record H1 EBITDA margin

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

  • Q2 2022: Sales from continuing operations grew by 29 % in local currency to CHF 1.301 billion, underpinned by strong pricing and volume expansion
  • Q2 2022: EBITDA margin increased to 16.6 % from 15.8 %, supported by operating leverage from strong sales growth, fully compensating raw material, energy, and logistics cost inflation
  • H1 2022: Sales from continuing operations increased by 29 % in local currency to CHF 2.563 billion
  • H1 2022: EBITDA margin increased to 17.0 % from 16.5 % – a record first half year EBITDA margin
  • Full Year 2022 Outlook: Strong local currency growth for the Group to around CHF 5.0 billion with the aim to improve the year-on-year Group EBITDA margin

Read more...


Clariant published its First Quarter Figures 2022 on 28 July 2022. 

CONFERENCE CALL AND WEBCAST

A live audio webcast and conference call took place the same day at 3 pm CEST.

Feel free to access the podcast of the conference call.

Page summary

Summarization in progress